Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This phase I trial investigates the effects of influenza vaccine in treating patients with stage I-IV melanoma. While intramuscular administration of influenza vaccine provides immunization against the influenza virus, giving influenza vaccine directly into the tumor (intralesional) may decrease the size of the injected melanoma tumor, or the extent of the melanoma within the body.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek od 18 do 99 lat
- •Potwierdzona diagnoza czerniaka skóry (stadium I-III lub IV)
- •Co najmniej jeden guz czerniaka o wymiarach co najmniej 1 cm, możliwy do wstrzyknięcia
- •Dobra ogólna kondycja zdrowotna (stopień wydolności 0-1)
- •Prawidłowe wyniki testów krwi: liczba neutrofili, hemoglobina, płytki krwi
- •Prawidłowe wyniki testów wątroby i nerek (badania z ostatnich 30 dni)
- •Uzdolnione do rozrodu kobiety muszą stosować antykoncepcję przez co najmniej 3-5 miesięcy po badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 99 Years
- Last updated (source)
- July 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Ohio State University Comprehensive Cancer Center
Columbus, United States
Trial contact
The Ohio State University Comprehensive Cancer Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.